Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Regenxbio (RGNX) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to $83.5 million.

  • Regenxbio's Accumulated Depreciation & Amortization rose 2046.17% to $83.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.5 million, marking a year-over-year increase of 2046.17%. This contributed to the annual value of $72.3 million for FY2024, which is 2636.69% up from last year.
  • According to the latest figures from Q3 2025, Regenxbio's Accumulated Depreciation & Amortization is $83.5 million, which was up 2046.17% from $80.1 million recorded in Q2 2025.
  • Regenxbio's Accumulated Depreciation & Amortization's 5-year high stood at $119.4 million during Q4 2021, with a 5-year trough of $24.6 million in Q1 2021.
  • Over the past 5 years, Regenxbio's median Accumulated Depreciation & Amortization value was $54.4 million (recorded in 2023), while the average stood at $55.6 million.
  • As far as peak fluctuations go, Regenxbio's Accumulated Depreciation & Amortization surged by 42651.94% in 2021, and later tumbled by 6533.17% in 2022.
  • Regenxbio's Accumulated Depreciation & Amortization (Quarter) stood at $119.4 million in 2021, then plummeted by 65.33% to $41.4 million in 2022, then surged by 38.22% to $57.2 million in 2023, then rose by 26.37% to $72.3 million in 2024, then increased by 15.56% to $83.5 million in 2025.
  • Its Accumulated Depreciation & Amortization was $83.5 million in Q3 2025, compared to $80.1 million in Q2 2025 and $76.2 million in Q1 2025.